OPINIONMallinckrodt Is Just One Of Dennis Kozlowski's Billion Dollar BabiesBy Dana BlankenhornFeb 12, 2014 11:22 AM EST
MERGERS AND ACQUISITIONSMallinckrodt Inks $1.3B Deal for CadenceBy Andrew BulkeleyFeb 11, 2014 10:21 AM EST
STOCKSCadence Pharmaceuticals' Management Presents At The 2012 Wedbush PACGROW Life Sciences Management Access Conference (Transcript)By Seeking AlphaAug 14, 2012 9:25 PM EDT
STOCKSCadence Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call TranscriptBy Seeking AlphaAug 3, 2012 1:28 AM EDT
STOCKSPacira: Exparel Approval Easy, Selling Painkiller Harder ChallengeBy Adam FeuersteinOct 31, 2011 11:08 AM EDT
INVESTING5 Stocks Showing Relative Strength in a Weak MarketBy Roberto PedoneSep 22, 2011 2:18 PM EDT
STOCKSCadence CEO Discusses Q3 2010 Results - Earnings Call TranscriptBy Seeking AlphaNov 5, 2010 2:34 PM EDT
